Our Manufacturing Sites & Certifications

OUR MANUFACTURING SITES

Our global expansion is mostly covered by our two state-of-the-art manufacturing facilities, with our largest one in Rodopi being recently approved by US FDA and other national and international authorities; with a total production capacity of over 3.8bn tablets, 2.2 bn capsules, 2.5m ampoules for injection and with over 20.400m2 of manufacturing space and 5.440 m2 of warehousing space, we are ranked among the top quality manufacturers based in Europe.

At a glance

MANUFACTURING SITE SAPES RODOPI

• FDA approved
• Focus: Large batch sizes of solid and sterile dosage forms
• In operation since June 2008 / extension in 2010 / extension in 2021
• Designed by German Group M&W
• Total: 15,300m2 o/w – Total surface area: 10,900m2 
• Production capacity:
  • Tablets – 3,3bn p.a.
  • Capsules – 1,2bn p.a.
  • Blisters – 175m p.a.
  • Sterile syringes & vials (LAI) – 4m p.a.
• Environmentally friendly investment
• One of the largest employers in the region
• Technologies: 
  • Oral Solids (tablets, coated tablets, capsules with pellets, microtablets, powders)
  • LAIs (vials, pre -filled syringes, dual chamber syringes, Pen assembly Nanosuspension, Lyophilisation)
• Certifications: USFDA / ANVISA / SFDA / EU GMP / DIGEMID GLP / ISO 9001 / ISO 14001 / ISO 13485

MANUFACTURING SITE PALLINI ATTICA

• 2.860 m2 Pallini plant
• 2.000 m2 Aspropyrgos warehouse
• Manufactures solid dosage forms & injectables
• Initiated in 1972
• Production capacity:
  • Tablets & Capsules – 800m p.a.
  • Blisters – 45m p.a.
  • Sterile vials – 1.5m p.a.
  • Sterile ampoules – 6m p.a.
• Technologies: 
  • Solids (coated and uncoated tablets, capsules with pellets, microtabs & powders)
  • Injectables low and high volume vials & ampoules)
• Certifications: EU GMP / SFDA / ISO 9001